1. Home
  2. ATAI vs CIVB Comparison

ATAI vs CIVB Comparison

Compare ATAI & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • CIVB
  • Stock Information
  • Founded
  • ATAI 2018
  • CIVB 1884
  • Country
  • ATAI Germany
  • CIVB United States
  • Employees
  • ATAI N/A
  • CIVB N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • CIVB Major Banks
  • Sector
  • ATAI Health Care
  • CIVB Finance
  • Exchange
  • ATAI Nasdaq
  • CIVB Nasdaq
  • Market Cap
  • ATAI 282.6M
  • CIVB 305.3M
  • IPO Year
  • ATAI 2021
  • CIVB N/A
  • Fundamental
  • Price
  • ATAI $1.46
  • CIVB $20.46
  • Analyst Decision
  • ATAI Strong Buy
  • CIVB Buy
  • Analyst Count
  • ATAI 3
  • CIVB 4
  • Target Price
  • ATAI $10.50
  • CIVB $22.67
  • AVG Volume (30 Days)
  • ATAI 1.8M
  • CIVB 41.6K
  • Earning Date
  • ATAI 05-14-2025
  • CIVB 04-24-2025
  • Dividend Yield
  • ATAI N/A
  • CIVB 3.43%
  • EPS Growth
  • ATAI N/A
  • CIVB N/A
  • EPS
  • ATAI N/A
  • CIVB 2.01
  • Revenue
  • ATAI $308,000.00
  • CIVB $149,094,000.00
  • Revenue This Year
  • ATAI $65.58
  • CIVB $15.59
  • Revenue Next Year
  • ATAI N/A
  • CIVB $5.38
  • P/E Ratio
  • ATAI N/A
  • CIVB $9.88
  • Revenue Growth
  • ATAI N/A
  • CIVB N/A
  • 52 Week Low
  • ATAI $1.03
  • CIVB $13.60
  • 52 Week High
  • ATAI $2.57
  • CIVB $23.70
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 52.18
  • CIVB 54.67
  • Support Level
  • ATAI $1.41
  • CIVB $18.80
  • Resistance Level
  • ATAI $1.51
  • CIVB $20.08
  • Average True Range (ATR)
  • ATAI 0.12
  • CIVB 0.97
  • MACD
  • ATAI 0.03
  • CIVB 0.13
  • Stochastic Oscillator
  • ATAI 87.50
  • CIVB 86.01

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

Share on Social Networks: